Cargando…

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

Surgery with curative intent can be offered to congenital hyperinsulinism (CHI) patients, provided that the lesion is focal. Radiolabeled exendin-4 specifically binds the glucagonlike peptide 1 receptor on pancreatic β-cells. In this study, we compared the performance of (18)F-DOPA PET/CT, the curre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boss, Marti, Rottenburger, Christof, Brenner, Winfried, Blankenstein, Oliver, Prasad, Vikas, Prasad, Sonal, de Coppi, Paolo, Kühnen, Peter, Buitinga, Mijke, Nuutila, Pirjo, Otonkoski, Timo, Hussain, Khalid, Brom, Maarten, Eek, Annemarie, Bomanji, Jamshed, Shah, Pratik, Gotthardt, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2022
Materias:	Featured Article of The Month
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805776/ https://www.ncbi.nlm.nih.gov/pubmed/34215672 http://dx.doi.org/10.2967/jnumed.121.262327

Ejemplares similares

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019)

Brain Imaging of the GLP-1 Receptor in Obesity Using (68)Ga-NODAGA-Exendin-4 PET
por: Deden, Laura N., et al.
Publicado: (2021)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
por: Kaeppeli, Simon A. M., et al.
Publicado: (2019)

Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [(68)Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method
por: Migliari, Silvia, et al.
Publicado: (2022)

Non-invasive in vivo determination of viable islet graft volume by (111)In-exendin-3
por: Eter, Wael A., et al.
Publicado: (2017)

Glucagon-like peptide-1 receptor expression after myocardial infarction: Imaging study using (68)Ga-NODAGA-exendin-4 positron emission tomography
por: Ståhle, Mia, et al.
Publicado: (2018)

Variation in Glycemic Outcomes in Focal Forms of Congenital Hyperinsulinism—The UK Perspective
por: Dastamani, Antonia, et al.
Publicado: (2022)

The Role of Glucagon-Like Peptide 1 Receptor PET/CT With Ga-68-NODAGA-exendin in Localising an Insulinoma: Lessons From a Clinical Case
por: Grigoriadou, Viktoria Chatzimavridou, et al.
Publicado: (2021)

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020)

A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
por: Jodal, Andreas, et al.
Publicado: (2014)

Importance of beta cell mass for glycaemic control in people with type 1 diabetes
por: Jansen, Theodorus J. P., et al.
Publicado: (2022)

The effect of purification of Ga-68-labeled exendin on in vivo distribution
por: Brom, Maarten, et al.
Publicado: (2016)

Stem Cell Based Models in Congenital Hyperinsulinism – Perspective on Practicalities and Possibilities
por: Lithovius, Väinö, et al.
Publicado: (2022)

(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
por: Brom, Maarten, et al.
Publicado: (2015)

Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin
por: Eter, Wael A., et al.
Publicado: (2015)

Esophageal ridges: an unusual complication of oral iron therapy
por: Sharma, Vishal, et al.
Publicado: (2017)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

New Radiolabeled Exendin Analogues Show Reduced Renal Retention
por: Joosten, Lieke, et al.
Publicado: (2023)

Kaspar Podgorski
por: Marx, Vivien
Publicado: (2020)

Manu Prakash
por: Marx, Vivien
Publicado: (2020)

Henry Colecraft
por: Marx, Vivien
Publicado: (2020)

When labs welcome under-represented groups
por: Marx, Vivien
Publicado: (2022)

Familial Focal Congenital Hyperinsulinism
por: Ismail, Dunia, et al.
Publicado: (2011)

Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging
por: Joosten, Lieke, et al.
Publicado: (2017)

Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer
por: Gotthardt, Martin, et al.
Publicado: (2018)

Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge
por: Stefanovski, Darko, et al.
Publicado: (2022)

Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis
por: Dorst, Daphne N, et al.
Publicado: (2020)

Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
por: Willekens, Stefanie M. A., et al.
Publicado: (2016)

Long-Term Outcome and Treatment in Persistent and Transient Congenital Hyperinsulinism: A Finnish Population-Based Study
por: Männistö, Jonna M E, et al.
Publicado: (2021)

Hyperinsulinism
Publicado: (1932)

Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin
por: van der Kroon, Inge, et al.
Publicado: (2017)

(18)F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster?
por: Boerman, Otto C., et al.
Publicado: (2011)

Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
por: Dorst, Daphne N., et al.
Publicado: (2021)

Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism
por: Welters, Alena, et al.
Publicado: (2018)

PET imaging during hypoglycaemia to study adipose tissue metabolism
por: Boss, Marti, et al.
Publicado: (2019)

Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, (18)F-labeled [Nle(14),Lys(40)]exendin-4 analog, shows promise for clinical imaging
por: Mikkola, Kirsi, et al.
Publicado: (2016)

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [(68)Ga]Ga-NODAGA-AMBA and [(44)Sc]Sc-NODAGA-AMBA
por: Kálmán-Szabó, Ibolya, et al.
Publicado: (2022)

GLP-1 Receptor Antagonist Exendin-(9-39) Elevates Fasting Blood Glucose Levels in Congenital Hyperinsulinism Owing to Inactivating Mutations in the ATP-Sensitive K(+) Channel
por: Calabria, Andrew C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k78vcbs7o9v6q5pnkjnjbpkteb